Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Curevac N.V.

Start price
Target price
Perf. (%)
€62.25
28.08.21
-
28.08.22
-3.82%
04.09.21

Stable Large shareholder and/or long term investor
Below average Marketposition
High risks for its business
Risky Investment
buy
Mag Silver Corp.

Start price
Target price
Perf. (%)
€16.16
28.08.21
-
28.08.22
-1.55%
13.03.22

Lang & Schwarz AG

Start price
Target price
Perf. (%)
€26.73
27.08.21
€20.00
12.01.22
3.62%
13.01.22

Below average Management
Higher risks for its business
Significant cyclical dependencies
Probably not worthwhile Investment
buy
Agfa Gevaert N.V.

Start price
Target price
Perf. (%)
€4.44
26.08.21
€5.50
26.08.22
-25.11%
27.08.22

Could be worthwhile Investment >10% per year
buy
Lang & Schwarz AG

Start price
Target price
Perf. (%)
€29.30
26.08.21
€46.00
26.08.22
-49.83%
27.08.22

Valuable balance sheet
Small Risks for its business
Differentiated customer and product portfolio
Good culture
buy
Doccheck AG NA

Start price
Target price
Perf. (%)
€28.20
26.08.21
-
26.08.22
-44.50%
26.08.22

buy
Eramet S.A.

Start price
Target price
Perf. (%)
€68.60
25.08.21
€70.00
25.08.22
11.01%
13.10.21

Could be worthwhile Investment >10% per year
buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€39.11
25.08.21
-
25.08.22
-0.28%
15.09.21

Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Probably not worthwhile Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€13.84
25.08.21
-
25.08.22
-32.23%
26.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.20
24.08.21
-
24.08.22
-24.81%
25.08.21

Probably not worthwhile Investment
buy
Bit Mining Ltd. ADR

Start price
Target price
Perf. (%)
€71.00
24.08.21
-
24.08.25
14.79%
15.10.21

Could be worthwhile Investment >10% per year
buy
adesso SE

Start price
Target price
Perf. (%)
€172.40
24.08.21
-
24.08.22
-27.49%
24.08.22

buy
Nynomic AG

Start price
Target price
Perf. (%)
€50.60
24.08.21
-
24.08.22
-40.71%
24.08.22

buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€30.20
24.08.21
-
24.08.22
16.56%
24.08.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€126.20
24.08.21
-
24.08.22
-67.27%
24.08.22

buy
Leoni AG

Start price
Target price
Perf. (%)
€16.65
24.08.21
-
24.08.22
-57.21%
24.08.22

buy
Basler AG

Start price
Target price
Perf. (%)
€141.60
24.08.21
-
24.08.22
-81.64%
24.08.22

buy
Heidelberger Druckmaschinen AG

Start price
Target price
Perf. (%)
€2.18
23.08.21
€2.40
23.08.22
-30.85%
24.08.22

Could be worthwhile Investment >10% per year
buy
Bilfinger SE

Start price
Target price
Perf. (%)
€29.22
23.08.21
€31.00
23.08.22
2.12%
24.08.22

Could be worthwhile Investment >10% per year
buy
Hypoport SE

Start price
Target price
Perf. (%)
€563.00
23.08.21
€570.00
23.08.22
-64.94%
24.08.22

Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€31.22
23.08.21
-
23.08.22
-18.39%
14.09.21

Could be worthwhile Investment >10% per year
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€20.42
23.08.21
-
23.08.22
23.56%
14.09.21

Could be very worthwhile Investment >20% year
Innovative
Some uniques
Future proof or reliable business model
buy
Endo International

Start price
Target price
Perf. (%)
€2.07
23.08.21
-
23.08.22
11.85%
14.09.21

Capable Management
buy
Orphazyme A/S

Start price
Target price
Perf. (%)
€4.98
23.08.21
€7.00
23.08.22
-17.27%
04.09.21

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Little innovation
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€22.67
23.08.21
€28.00
23.08.22
-0.88%
04.09.21

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques